Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids
Chengcheng Zhao(Heilongjiang University of Chinese Medicine), Dao Wen Wang(Tongji Hospital), Liyuan Peng(Tongji Hospital), Zuowen He(Tongji Hospital), Qiumeng Zhang(East China Normal University), Feipu Yang(Chinese Academy of Sciences), Xiangrui Jiang(Chinese Academy of Sciences), Huihui Li(Xiangya Hospital Central South University), Chen Chen(Tongji Hospital), Yan Zhang(Southwest Minzu University), Wen Zheng(Unknown), Yinhui Wang(Tongji Hospital), Junfang Wu(Laboratory of Molecular Genetics), Jingshan Shen(Shanghai Institute of Materia Medica)
Cited by 6
Related Papers
The role of CD36 in cardiovascular disease
|Cardiovascular Research|2020|273
Gut Microbiota Composition Modifies Fecal Metabolic Profiles in Mice
|Journal of Proteome Research|2013|225
Health risk assessment of polycyclic aromatic hydrocarbons in the source water and drinking water of China: Quantitative analysis based on published monitoring data
|The Science of The Total Environment|2011|207